Analysis of laboratory testing results collected in an enhanced chlamydia surveillance system in Australia, 2008-2010

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Dimech, Wayne ^a   Lim, Megan S C ^b,c   Van Gemert, Caroline ^b,c   Guy, Rebecca ^d   Boyle, Douglas ^e   Donovan, Basil ^d,f   Hellard, Margaret ^b,c  

^a NRL   (Australia)

^b BURNET INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f SYDNEY EYE HOSPITAL   (Australia)

Author keywords

ACCESS laboratory network; Chlamydia trachomatis; Sexually transmitted infection; Surveillance

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BACTERIUM CULTURE; CHLAMYDIA; CHLAMYDIASIS; COMPUTER PROGRAM; DISEASE SURVEILLANCE; EYE; FEMALE; HIGH RISK POPULATION; HOSPITAL INFORMATION SYSTEM; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; RECTUM; SEX DIFFERENCE; THROAT CULTURE; URETHRA; URINALYSIS; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR KIT;

ADOLESCENT; ADULT; AUSTRALIA; CHLAMYDIA; CHLAMYDIA INFECTIONS; FEMALE; GENERAL PRACTICE; HUMANS; LABORATORIES, HOSPITAL; MALE; SENTINEL SURVEILLANCE; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84902551567     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-325     Document Type: Article

References (58)

1. National Notifiable Diseases Surveillance System. http://www9.health.gov.au/cda/source/cda-index.cfm.
2. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997, 10(1):160-184. 172947, 8993862.
3. Global incidence and prevalence of selected curable sexually transmitted infections- 2008. http://apps.who.int/iris/bitstream/10665/75181/1/9789241503839_eng.pdf.
4. Adams EJ, LaMontagne DS, Johnston AR, Pimenta JM, Fenton KA, Edmunds WJ. Modelling the healthcare costs of an opportunistic chlamydia screening programme. Sex Transm Infect 2004, 80(5):363-370. 10.1136/sti.2004.009654, 1744903, 15459403.
5. Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mardh PA, Stary A, Stray-Pedersen B. Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect 2002, 78(6):406-412. 10.1136/sti.78.6.406, 1758346, 12473799.
6. Johnson RN, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, Steece R, Markowitz LE, Devine OJ, Walsh CM, Wang S, Gunter DC, Irwin KL, DeLisle S, Berman SM. Screening Tests To Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections - 2002. MMWR 2002, 51:RR15.
7. Clarke LM, Sierra MF, Daidone BJ, Lopez N, Covino JM, McCormack WM. Comparison of the Syva MicroTrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population. J Clin Microbiol 1993, 31(4):968-971. 263595, 7681852.
8. Chalker VJ, Vaughan H, Patel P, Rossouw A, Seyedzadeh H, Gerrard K, James VL. External quality assessment for detection of Chlamydia trachomatis. J Clin Microbiol 2005, 43(3):1341-1347. 10.1128/JCM.43.3.1341-1347.2005, 1081298, 15750105.
9. Chan EL, Brandt K, Stoneham H, Antonishyn N, Horsman GB. Comparison of the effectiveness of polymerase chain reaction and enzyme immunoassay in detecting Chlamydia trachomatis in different female genitourinary specimens. Arch Pathol Lab Med 2000, 124(6):840-843.
10. Mumtaz G, Clark S, Ridgway GL, Miller CJ, Johal B, Allason Jones E. Comparison of an enzyme immuno assay (Antigenz Chlamydia) with cell culture for the detection of genital chlamydial infection in high and low risk populations. Genitourin Med 1993, 69(2):119-122. 1195043, 8509091.
11. Schachter J. DFA, EIA, PCR, LCR and other technologies: what tests should be used for diagnosis of chlamydia infections?. Immunol Investig 1997, 26(1-2):157-161.
12. Schachter J, Jones RB, Butler RC, Rice B, Brooks D, Van der Pol B, Gray M, Moncada J. Evaluation of the Vidas Chlamydia test to detect and verify Chlamydia trachomatis in urogenital specimens. J Clin Microbiol 1997, 35(8):2102-2106. 229911, 9230390.
13. Gaydos CA, Cartwright CP, Colaninno P, Welsch J, Holden J, Ho SY, Webb EM, Anderson C, Bertuzis R, Zhang L, Miller T, Leckie G, Abravaya K, Robinson J. Performance of the Abbott RealTime CT/NG for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2010, 48(9):3236-3243. 10.1128/JCM.01019-10, 2937681, 20668135.
14. Stevens MP, Twin J, Fairley CK, Donovan B, Tan SE, Yu J, Garland SM, Tabrizi SN. Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination. J Clin Microbiol 2010, 48(6):2060-2065. 10.1128/JCM.02308-09, 2884500, 20392903.
15. Ho MK, Lo JY, Lo AC, Cheng FK, Chan FK. Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting. Sex Transm Infect 2009, 85(5):322-325. 10.1136/sti.2008.035220, 19406739.
16. Chen MY, Donovan B. Changes in testing methods for genital Chlamydia trachomatis in New South Wales, Australia, 1999 to 2002. Sexual health 2005, 2(4):251-253. 10.1071/SH04028, 16402674.
17. National Management Guidelines for Sexually Transmissible Infections 7th Edition. http://mshc.org.au/Portals/6/NMGFSTI.pdf.
18. Sexually transmitted infection guideline for men who have sex with men 2010. http://www.ashm.org.au/images/publications/guidelines/msmtestingguidelines2010.pdf.
19. Physicians; RACo Confidential Health Care for Adolescents and Young People (12-24 years) 2010, Sydney: Royal Australian College of Physicians, Physicians; RACo.
20. Slater W, Sadler K, Cassell JA, Horner P, Low N. What can be gained from comprehensive disaggregate surveillance? The Avon Surveillance System for Sexually Transmitted Infections. Sex Transm Infect 2007, 83(5):411-415. 10.1136/sti.2006.023440, 2659036, 17344247.
21. Lim MS, Bowring AL, Gold J, Aitken CK, Hellard ME. Trends in sexual behavior, testing, and knowledge in young people; 2006-2011. Sex Transm Dis 2012, 39(11):831-834. 10.1097/OLQ.0b013e3182663f27, 23064530.
22. Rissel CE, Richters J, Grulich AE, de Visser RO, Smith AM. Sex in Australia: first experiences of vaginal intercourse and oral sex among a representative sample of adults. Aust New Zeal J Publ Health 2003, 27(2):131-137.
23. Moller JK, Pedersen LN, Persson K. Comparison of the Abbott RealTime CT new formulation assay with two other commercial assays for detection of wild-type and new variant strains of Chlamydia trachomatis. J Clin Microbiol 2010, 48(2):440-443. 10.1128/JCM.01446-09, 2815632, 20007394.
24. Moller JK, Pedersen LN, Persson K. Comparison of Gen-probe transcription-mediated amplification, Abbott PCR, and Roche PCR assays for detection of wild-type and mutant plasmid strains of Chlamydia trachomatis in Sweden. J Clin Microbiol 2008, 46(12):3892-3895. 10.1128/JCM.00412-08, 2593266, 18842934.
25. Gilsdorf A, Hofmann A, Hamouda O, Bremer V. Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005. BMC Infect Dis 2010, 10:98. 10.1186/1471-2334-10-98, 2873557, 20403184.
26. Meader E, Waters J, Sillis M. Chlamydia trachomatis RNA in the environment: is there potential for false-positive nucleic acid amplification test results?. Sex Transm Infect 2008, 84(2):107-110. 10.1136/sti.2007.027862, 17971374.
27. Australian Government Second National Sexually Transmissible Infections Strategy 2010-2013. 2010, Commonwealth of Australia, Ageing Department of Health and Ageing, http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-national-strategies-2010-sti, Australian Government.
28. Gold J, Goller J, Hellard M, Lim MS, Hocking J, Fairley CK, Spelman T, McNamee K, Clift P, Guy R. Impact evaluation of a youth sexually transmissible infection awareness campaign using routinely collected data sources. Sexual health 2011, 8(2):234-241. 10.1071/SH10082, 21592439.
29. Pedrana A, Hellard M, Guy R, El-Hayek C, Gouillou M, Asselin J, Batrouney C, Nguyen P, Stoove M. Stop the drama Downunder: a social marketing campaign increases HIV/sexually transmitted infection knowledge and testing in Australian gay men. Sex Transm Dis 2012, 39(8):651-658. 10.1097/OLQ.0b013e318255df06, 22801349.
30. Gold J, Lim MS, Hellard ME, Hocking JS, Keogh L. What's in a message? Delivering sexual health promotion to young people in Australia via text messaging. BMC public health 2010, 10:792. 10.1186/1471-2458-10-792, 3022861, 21190584.
31. Gold J, Lim MS, Hocking JS, Keogh LA, Spelman T, Hellard ME. Determining the impact of text messaging for sexual health promotion to young people. Sex Transm Dis 2011, 38(4):247-252.
32. Lister NA, Smith A, Read T, Fairley CK. Testing men who have sex with men for Neisseria gonorrhoeae and Chlamydia trachomatis prior to the introduction of guidelines at an STD clinic in Melbourne. Sexual health 2004, 1(1):47-50. 10.1071/SH03005, 16335295.
33. Kong FY, Hocking JS, Link CK, Chen MY, Hellard ME. Sex and sport: chlamydia screening in rural sporting clubs. BMC Infect Dis 2009, 9:73. 10.1186/1471-2334-9-73, 2695469, 19470183.
34. Bilardi JE, Fairley CK, Temple-Smith MJ, Pirotta MV, McNamee KM, Bourke S, Gurrin LC, Hellard M, Sanci LA, Wills MJ, Walker J, Chen MY, Hocking JS. Incentive payments to general practitioners aimed at increasing opportunistic testing of young women for chlamydia: a pilot cluster randomised controlled trial. BMC public health 2010, 10:70. 10.1186/1471-2458-10-70, 2841675, 20158918.
35. Bilardi JE, Hopkins CA, Fairley CK, Hocking JS, Tomnay JE, Pavlin NL, Parker RM, Temple-Smith MJ, Bowden FJ, Russell DB, Pitts M, Chen MY. Innovative resources could help improve partner notification for chlamydia in primary care. Sex Transm Dis 2009, 36(12):779-783. 10.1097/OLQ.0b013e3181b357f6, 19704390.
36. Walker J, Fairley CK, Walker SM, Gurrin LC, Gunn JM, Pirotta MV, Carter R, Hocking JS. Computer reminders for Chlamydia screening in general practice: a randomized controlled trial. Sex Transm Dis 2010, 37(7):445-450.
37. Ali H, Guy RJ, Fairley CK, Wand H, Chen MY, Dickson B, O'Connor CC, Marshall L, Grulich AE, Kaldor JM, Hellard ME, Donovan B. Understanding trends in genital Chlamydia trachomatis can benefit from enhanced surveillance: findings from Australia. Sex Transm Infect 2012, 88(7):552-557. 10.1136/sextrans-2011-050423, 22645390.
38. Donovan B. Rising prevalence of genital Chlamydia trachomatis infection in heterosexual patients at the Sydney Sexual Health Centre, 1994 to 2000. Commun Dis Intell Q Rep 2002, 26(1):51-55.
39. Guy RJ, Wand H, Franklin N, Fairley CK, Chen MY, O'Connor CC, Marshall L, Grulich AE, Kaldor JM, Hellard ME, Donovan B. Chlamydia trends in men who have sex with men attending sexual health services in Australia, 2004-2008. Sex Transm Dis 2011, 38(4):339-346.
40. O'Rourke KM, Fairley CK, Samaranayake A, Collignon P, Hocking JS. Trends in Chlamydia positivity over time among women in Melbourne Australia, 2003 to 2007. Sex Transm Dis 2009, 36(12):763-767. 10.1097/OLQ.0b013e3181b12765, 19801964.
41. Vodstrcil LA, Fairley CK, Fehler G, Leslie D, Walker J, Bradshaw CS, Hocking JS. Trends in chlamydia and gonorrhea positivity among heterosexual men and men who have sex with men attending a large urban sexual health service in Australia, 2002-2009. BMC Infect Dis 2011, 11:158. 10.1186/1471-2334-11-158, 3138447, 21639943.
42. Lim MSC E-HC, Goller JL, Fairley CK, Nguyen P, Hamilton R, Henning D, McNamee K, Hellard ME, Stoove M. Trends in chlamydia positivity among heterosexual patients from the Victorian Primary Care Sentinel Surveillance Network, 2007-2011. Med J Aust 2013, in press.
43. Goller JL, Guy RJ, Gold J, Lim MS, El-Hayek C, Stoove MA, Bergeri I, Fairley CK, Leslie DE, Clift P, White B, Hellard ME. Establishing a linked sentinel surveillance system for blood-borne viruses and sexually transmissible infections: methods, system attributes and early findings. Sexual health 2010, 7(4):425-433. 10.1071/SH09116, 21062582.
44. Guy RJ, Kong F, Goller J, Franklin N, Bergeri I, Dimech W, Reilly N, Sullivan E, Ward J, Kaldor JM, Hellard ME, Donovan B. A new national Chlamydia Sentinel Surveillance System in Australia: evaluation of the first stage of implementation. Commun Dis Intell Q Rep 2010, 34(3):319-328.
45. Stevens MP, Tan SE, Horvath L, Fairley CK, Garland SM, Tabrizi SN. Absence of a Chlamydia trachomatis variant, harbouring a deletion in the cryptic plasmid, in clients of a sexually transmissible infection clinic and antenatal patients in Melbourne. Commun Dis Intell Q Rep 2008, 32(1):77-81.
46. Siaw-Teng L, Boyle D. Secure Data Linkage and Information Sharing With GRHANITE™. HIC 2008 Australia's Health Informatics Conference 2008, Health Informatics Society of Australia Ltd (HISA), http://www.vicc.org/biostatistics/download/Melbourne/GRHANITE_Descriptive_Paper200810.pdf.
47. Australia's notifiable diseases status: Annual report of the National Notifiable Diseases Surveillance System. https://www.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-annlrpt-nndssar.htm.
48. Bowring A, Goller J, Gouillou M, Harvey C, Bateson D, McNamee K, Read C, Boyle D, Joradn L, Wardle R, Stephens A, Donovan B, Guy RJ, Hellard ME. Chlamydia testing and retesting patterns at family planning clinics in Australia. Sexual Health 2013, 10(1):74-81.
49. Chen MY, Rohrsheim R, Donovan B. The differing profiles of symptomatic and asymptomatic Chlamydia trachomatis-infected men in a clinical setting. Int J STD AIDS 2007, 18(6):384-388. 10.1258/095646207781024810, 17609026.
50. Burnet Institute Australian Collaboration for Chlamydia Enhanced Sentinel Surveillance: General Practice Clinic Network Report, 2008-2010 2012, Burnet Institute, http://www.burnet.edu.au/system/asset/file/1380/GP_Network_ACCESS_Report_2008_2010.pdf, Burnet Institute.
51. Lewis D, Newton DC, Guy RJ, Ali H, Chen MY, Fairley CK, Hocking JS. The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis. BMC Infect Dis 2012, 12:113. 10.1186/1471-2334-12-113, 3462140, 22583480.
52. Burnet Institute Australian Collaboration for Chlamydia Enhanced Sentinel Surveillance: Family Planning Clinics Network Report, 2008-2010 2012, Burnet Institute, http://www.burnet.edu.au/system/asset/file/1379/FPC_Network_ACCESS_Report_2008_2010.pdf, Burnet Institute.
53. Jin F, Prestage GP, Mao L, Kippax SC, Pell CM, Donovan B, Cunningham PH, Templeton DJ, Kaldor JM, Grulich AE. Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study. Sex Transm Infect 2007, 83(2):113-119. 10.1136/sti.2006.021915, 2598603, 17005541.
54. Lim MSC, Goller JL, Guy RJ, Gold J, Stoove M, Hocking JS, Fairley CK, Henning D, McNamee K, Owen L, Sheehan P, Hellard ME. Correlates of Chlamydia trachomatis infection in a primary care sentinel surveillance network. Sexual health 2012, 9:247-253. 10.1071/SH11019, 22697142.
55. Alexander S. The challenges of detecting gonorrhoea and chlamydia in rectal and pharyngeal sites: could we, should we, be doing more?. Sex Transm Infect 2009, 85(3):159-160. 10.1136/sti.2008.035469, 19478103.
56. Lister NA, Tabrizi SN, Fairley CK, Garland S. Validation of roche COBAS Amplicor assay for detection of Chlamydia trachomatis in rectal and pharyngeal specimens by an omp1 PCR assay. J Clin Microbiol 2004, 42(1):239-241. 10.1128/JCM.42.1.239-241.2004, 321736, 14715759.
57. Bachmann LH, Johnson RE, Cheng H, Markowitz L, Papp JR, Palella FJ, Hook EW. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J Clin Microbiol 2010, 48(5):1827-1832. 10.1128/JCM.02398-09, 2863861, 20335410.
58. Medicare Australia Statistics for Medicare Item 69316. https://www.medicareaustralia.gov.au/statistics/mbs_item.shtml.